Modulation of mitomycin C mutagenicity on Saccharomyces cerevisiae by glutathione, cytochrome P-450, and mitochondria interactions

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 390, Issue 1-2, 1997, Pages 113-120

  Rossi, Carlo ^a   Poli, Paola ^a   Candi, Alessia ^a   Buschini, Annamaria ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b Biotecnologika Scrl   (Italy)

Author keywords

Antiblastic drug; Gene conversion; Point mutation; Respiratory deficient mutant; Short term mutagenesis assay; Yeast

Indexed keywords

CYTOCHROME P450; GLUTATHIONE; MITOMYCIN C;

ARTICLE; CONTROLLED STUDY; MITOCHONDRION; MUTAGENICITY; MUTANT; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

SACCHAROMYCES CEREVISIAE;

EID: 0030906840     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1218(97)00007-4     Document Type: Article

References (54)

1. Iyer, V.N. and W. Szybalski (1963) Molecular mechanism of mitomycin action: linking of complementary DNA strands, Proc. Natl. Acad. Sci. USA, 50, 355-362.
2. Lin, A.J., L.A. Cosby and A.C. Sartorelli (1976) Potential bioreductive alkylating agents, in: A.C. Sartorelli (Ed.), Cancer Chemotherapy, American Chemical Society, Washington, DC, pp. 71-86.
3. Pan, S.S., T. Iracki and N.R. Bachur (1986) DNA alkylation by enzyme-activated mitomycin C, Mol. Pharmacol., 29, 622-628.
4. Egbertson, M. and S.J. Danishefsky (1987) Modeling of the electrophilic activation of mitomycins: chemical evidence for the intermediacy of a mitosene semiquinone as the active electrophile, J. Am. Chem. Soc., 109, 2204-2205.
5. Pritsos, C.A. and A.C. Sartorelli (1986) Generation of reactive oxygen radicals through bioactivation of mitomycin C antibiotic, Cancer Res., 46, 3528-3532.
6. Tomasz, M., D. Chowdary, R. Lipman, S. Shimotakahara, D. Veiro, V. Walker and G.L. Verdine (1986) Reaction of DNA with chemically or enzymatically activated mitomycin C: isolation and structure of the major covalent adduct, Proc. Natl. Acad. Sci. USA, 83, 6702-6706.
7. Tomasz, M., R. Lipman, D. Chowdary, J. Pawlak, G.L. Verdine and K. Nakanishi (1987) Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA, Science, 235, 1204-1208.
8. Lown, J.W., A. Begleiter, D. Johnson and A.R. Morgan (1976) Studies related to antitumor antibiotics. V. Reaction of mitomycin C with DNA examined by ethidium fluorescence assay, Can. J. Biochem., 54, 110-119.
9. Pan, S.S., P.A. Andrews, C.J. Glover and N.R. Bachur (1984) Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH cytochrome P-450 reductase and xanthine oxidase, J. Biol. Chem., 259, 959-966.
10. Dusre, L., S. Rajagopalan, H.M. Eliot, J.M. Covey and B.K. Sinha (1990) DNA interstrand cross-link and free radical formation in a human multidrug-resistant cell line from mitomycin C and its analogues, Cancer Res., 50, 648-652.
11. 5 reductase, Proc. Am. Assoc. Cancer Res., 32, 397-401.
12. Begleiter, A., E. Robotham and M.K. Leith (1992) Role of NAD(P)H: (quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia, Mol. Pharmacol., 41, 677.
13. Dorr, R.T., J.D. Liddil, J.M. Trent and W.S. Dalton (1987) Mitomycin C resistant L1210 leukemia cells: association with pleiotropic drug resistance, Biochem. Pharmacol., 36, 3115-3120.
14. McGurl, J. and K.A. Kennedy (1989) Effect of glutathione (GSH) depletion by diethylmalate (DEM) or buthionine-S,R-sulfoximine (BSO) on mitomycin C (MC) toxicity towards EMT6 mouse mammary tumor cells, Proc. Am. Assoc. Cancer Res., 30, 543.
15. Xu, B.H. and S.V. Singh (1992) Potentiation of mitomycin C cytotoxicity by glutathione depletion in a multi-drug resistant mouse leukemia cell line, Cancer Lett., 66, 49-53.
16. Perry, R.R., Y. Kang and B. Greaves (1993) Biochemical characterization of a mitomycin C resistant colon cancer cell line variant, Biochem. Pharmacol., 46, 1999-2005.
17. Xu, B.H., V. Gupta and S.V. Singh (1994) Mitomycin C sensitivity in human bladder cancer cell: possible role of glutathione and glutathione transferase in resistance, Arch. Biochem. Biophys., 308, 164-170.
18. Perry, R.R., B.R. Greaves, U. Rasberry and S.C. Barranco (1995) Effect of treatment duration and glutathione depletion on mitomycin C, Cancer Res., 52, 4608-4612.
19. Tomasz, M. and R. Lipman (1981) Reductive metabolism and alkylating activity of mitomycin C induced by rat liver microsomes, Biochemistry, 20, 556-561.
20. Kennedy, K.A., S.G. Sligar, L. Polomski and A.C. Sartorelli (1982) Metabolite activation of mitomycin C by liver microsomes and nuclei, Biochem. Pharmacol., 31, 211-216.
21. Hoban, P.R., M.I. Walton, C.N. Robson, J. Godden, I.J. Stratford, P. Workman, A.L. Harris and I.D. Hickson (1990) Decreased NADPH: cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions, Cancer Res., 50, 4692-4697.
22. Kuehl, B.L., M. Buchwald and A.M. Rauth (1993) Characterization of a set of Chinese hamster ovary variant cell lines demonstrating differing sensitivity to mitomycin C, Oncol. Res., 5, 213-221.
23. Marshall, R.S., M.C. Patterson and A.M. Rauth (1989) Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions, Br. J. Cancer, 59, 341-346.
24. Dulhanty, A.M. and G.F. Whitmore (1991) Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase, Cancer Res., 51, 1860-1865.
25. O'Dwyer, P.J., K.S. Yao, A.K. Godwin and M. Clayon (1993) Effects of hypoxia upon detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells, Proc. Am. Assoc. Cancer Res., 34, 12.
26. Silva, J.M., S. Khan and P.J. O'Brien (1993) Contrasting molecular cytotoxic mechanisms of mitomycin C and its two analogs, BMY25282 and BMY25067, in isolated rat hepatocytes, Biochem. Pharmacol., 45, 2303-2309.
27. Kennedy, K.A., S. Rockwell and A.C. Sartorelli (1980) Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells, Cancer Res., 40, 2356-2360.
28. Rockwell, S. (1983) Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo, J. Natl. Cancer Inst., 71, 765-771.
29. Zimmermann, F.K., R. Kern and H. Rasenberg (1975) A yeast for simultaneous detection of induced mitotic crossing-over, mitotic gene conversion and reverse mutation, Mutation Res., 28, 381-388.
30. Ferguson, L.R. and P.M. Turner (1988) Mitotic crossing-over by anticancer drugs in Saccharomyces cerevisiae strain D5, Mutation Res., 204, 239-249.
31. Ferguson, L.R. and P.M. Turner (1988) `Petite' mutagenesis by anticancer drugs in Saccharomyces cerevisiae, Eur. J. Cancer Clin. Oncol., 24, 591-596.
32. Ferguson, L.R. and R.C. von Borstel (1992) Induction of the cytoplasmic `petite' mutation by chemical and physical agents in Saccharomyces cerevisiae, Mutation Res., 265, 103-148.
33. Nagley, P. and A.W. Linnane (1972) Biogenesis of mitochondria. XXI. Studies on the nature of the mitochondrial genome in yeast: the degenerative effects of ethidium bromide on mitochondrial genetic information in a respiratory competent strain, Mol. Biol., 66, 181-193.
34. Morineau, G., M. Azoulay and F. Frappier (1989) Reaction of o-phthalaldehyde with aminoacids and glutathione. Application to high-performance liquid chromatography determination, J. Chromatogr., 467, 209-216.
35. Omura, T. and R. Sato (1964) The carbon monoxide-binding pigment of liver microsome. I. Evidence for its hemoprotein nature, J. Biol. Chem., 239, 2370-2378.
36. Magni, G.E. and R.C. von Borstel (1962) Different rates of spontaneous mutation during mitosis and meiosis in yeast, Genetics, 47, 1097-1108.
37. Chu, K.C., K.M. Patel, A.H. Lin, R.E. Tarone, M.S. Linhart and V.C. Dunkel (1981) Evaluating statistical analysis and reproducibility of microbial mutagenicity of microbial mutagenicity assays, Mutation Res., 85, 119-132.
38. Wieseman, A., T.-K. Lim and L.F.J. Woods (1978) Regulation of the biosynthesis of cytochrome P-450 in brewer's yeast. Role of cyclic AMP, Biochem. Biophys. Acta, 544, 615-623.
39. Kärenlampi, S.O., E. Marin and O.O.P. Hänninen (1981) Effect of carbon source on the accumulation of cytochrome P-450 in the yeast Saccharomyces cerevisiae, Biochem. J., 194, 407-413.
40. von Borstel, R.C., D.F. O'Connell, R.D. Metha and U.G.G. Henning (1985) Modulation in cytochrome P-420 and P-450 content in Saccharomyces cerevisiae according to physiological conditions and genetic background, Mutation Res., 150, 217-224.
41. White, R.E. and M.J. Coon (1980) Oxygen activation by cytochrome P-450, Annu. Rev. Biochem., 49, 315-356.
42. 5, J. Biol. Chem., 259, 15377-15385.
43. 5 interactions: crosslinking of the phospholipid vesicle-associated proteins by a water-soluble carbodiimide, Arch. Biochem. Biophys., 241, 386-396.
44. 5, J. Biol. Chem., 260, 4007-4015.
45. Maccubin, A.E., N. Ersing, E.E. Budzinski, H.C. Box and H.L. Gurtoo (1994) Formation of 8-hydroxyguanine in DNA during mitomycin C activation, Cancer Biochem. Biophys., 14, 183-191.
46. Goeptar, A.R., J.M. te Koppele, H.R. Glatt, E.J. Groot, A. Seidel, M. Barrenscheen, C. Wolfel, J. Doehmer and N.P. Vermeulen (1995) The cytotoxicity of mitomycin C and adriamycin in genetically engineered V79 cell lines and freshly isolated rat hepatocytes, Chem. Biol. Interact., 97, 149-168.
47. Hercbergs, A., F. Brok-Simoni, F. Holtzman, J. Bar-Am, J.T. Leith and H.J. Brenner (1992) Erythrocyte glutathione and tumour response to chemotherapy, Lancet, 339, 1074-1076.
48. Ozols, R.F. (1992) Role of chemotherapy in the future treatment of ovarian cancer, Acta Obstet. Gynecol. Scand., 155, 55-60.
49. Ono, K. and D.C. Shrieve (1986) Enhancement of EMT6/SF tumor cell killing by mitomycin C and cyclophosphamide following in vivo administration of buthionine sulfoximine, Int. J. Radiat. Oncol. Biol. Phys., 12, 1175-1178.
50. Shrieve, D.C. and J.W. Harris (1986) Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation, Int. J. Radiat. Oncol. Biol. Phys., 12, 1171-1174.
51. Geard, C.R. and M.A. Georgsson (1986) Glutathione levels and cytotoxicity of a thiol activated alkylating agent in human and mouse cells, Int. J. Radiat. Oncol. Biol. Phys., 12, 1179-1182.
52. Lee, K.E. and R.D. Mayer (1989) Effects of systemic glutathione depletion by buthionine sulfoximine on sensitivity of murine bladder cancer to cytotoxic agents, Urology, 34, 376-380.
53. Siemann, D.W. and K.L. Beyers (1993) In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy, Br. J. Cancer, 68, 1071-1079.
54. Sharma, M., Q.-Y. He and M. Tomasz (1994) Effects of glutathione on alkylation and cross-linking of DNA by mitomycin C. Isolation of a ternary glutathione-mitomycin-DNA adduct, Chem. Res. Toxicol., 7, 401-407.